Home LiteratureArticle Details
PMID: 16322158 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Pediatrics ·Vol. 116 ·No. 6 ·2005-12-00 ·Pages 1353-60

Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, National Institutes of Child Health and Human Development Neonatal Research Network

Abstract

A number of definitions of bronchopulmonary dysplasia (BPD), or chronic lung disease, have been used. A June 2000 National Institute of Child Health and Human Development/National Heart, Lung, and Blood Institute Workshop proposed a severity-based definition of BPD for infants <32 weeks' gestational age (GA). Mild BPD was defined as a need for supplemental oxygen (O2) for > or =28 days but not at 36 weeks' postmenstrual age (PMA) or discharge, moderate BPD as O2 for > or =28 days plus treatment with <30% O2 at 36 weeks' PMA, and severe BPD as O2 for > or =28 days plus > or =30% O2 and/or positive pressure at 36 weeks' PMA. The objective of this study was to determine the predictive validity of the severity-based, consensus definition of BPD. Data from 4866 infants (birth weight < or =1000 g, GA <32 weeks, alive at 36 weeks' PMA) who were entered into the National Institute of Child Health and Human Development Neonatal Research Network Very Low Birth weight (VLBW) Infant Registry between January 1, 1995 and December 31, 1999, were linked to data from the Network Extremely Low Birth Weight (ELBW) Follow-up Program, in which surviving ELBW infants have a neurodevelopmental and health assessment at 18 to 22 months' corrected age. Linked VLBW Registry and Follow-up data were available for 3848 (79%) infants. Selected follow-up outcomes (use of pulmonary medications, rehospitalization for pulmonary causes, receipt of respiratory syncytial virus prophylaxis, and neurodevelopmental abnormalities) were compared among infants who were identified with BPD defined as O2 for 28 days (28 days definition), as O2 at 36 weeks' PMA (36 weeks' definition), and with the consensus definition of BPD. A total of 77% of the neonates met the 28-days definition, and 44% met the 36-weeks definition. Using the consensus BPD definition, 77% of the infants had BPD, similar to the cohort identified by the 28-days definition. A total of 46% of the infants met the moderate (30%) or severe (16%) consensus definition criteria, identifying a similar cohort of infants as the 36-weeks definition. Of infants who met the 28-days definition and 36-weeks definition and were seen at follow-up at 18 to 22 months' corrected age, 40% had been treated with pulmonary medications and 35% had been rehospitalized for pulmonary causes. In contrast, as the severity of BPD identified by the consensus definition worsened, the incidence of those outcomes and of selected adverse neurodevelopmental outcomes increased in the infants who were seen at follow-up. The consensus BPD definition identifies a spectrum of risk for adverse pulmonary and neurodevelopmental outcomes in early infancy more accurately than other definitions.

MeSH Terms
Bronchopulmonary Dysplasia/classification,diagnosis,physiopathology Child Development Consensus Developmental Disabilities/etiology Humans Infant Infant, Newborn Infant, Premature Infant, Very Low Birth Weight Lung Diseases/etiology National Institutes of Health (U.S.) Predictive Value of Tests Reproducibility of Results Respiratory Physiological Phenomena Risk Assessment Severity of Illness Index United States
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Ehrenkranz Richard A
Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520-8064, USA. [email protected]
Walsh Michele C
Vohr Betty R
Jobe Alan H
Wright Linda L
Fanaroff Avroy A
Wrage Lisa A
Poole Kenneth
National Institutes of Child Health and Human Development Neonatal Research Network
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
1098-4275
Published
2005-12-00
Pages
1353-60
Language
English
Region
United States
NLM ID
0376422
Subset
IM
Grants
NCRR NIH HHS · M01 RR 00070 · United States
NCRR NIH HHS · M01 RR 00750 · United States
NCRR NIH HHS · M01 RR 00997 · United States
NCRR NIH HHS · M01 RR 01032 · United States
NCRR NIH HHS · M01 RR 02172 · United States
NCRR NIH HHS · M01 RR 02635 · United States
NCRR NIH HHS · M01 RR 06022 · United States
NCRR NIH HHS · M01 RR 08084 · United States
NICHD NIH HHS · U01 HD36790 · United States
NICHD NIH HHS · U10 HD21364 · United States
NICHD NIH HHS · U10 HD21373 · United States
NICHD NIH HHS · U10 HD21385 · United States
NICHD NIH HHS · U10 HD21397 · United States
NICHD NIH HHS · U10 HD21415 · United States
NICHD NIH HHS · U10 HD27851 · United States
NICHD NIH HHS · U10 HD27853 · United States
NICHD NIH HHS · U10 HD27871 · United States
NICHD NIH HHS · U10 HD27880 · United States
NICHD NIH HHS · U10 HD27904 · United States
NICHD NIH HHS · U10 HD34167 · United States
NICHD NIH HHS · U10 HD34216 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]